Pulse Biosciences, Inc Common Stock (DE) (PLSE) is a publicly traded Healthcare sector company. As of October 22, 2026, PLSE trades at $52.67 with a market cap of $3.66B and a P/E ratio of -42.10. PLSE moved +2.92% today. Year to date, PLSE is +260.82%; over the trailing twelve months it is +205.39%. Its 52-week range spans $12.56 to $58.90. Analyst consensus is strong buy with an average price target of $62.33. Rallies surfaces PLSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PLSE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $52.67 |
| Market Cap | $3.66B |
| P/E Ratio | -42.10 |
| EPS | $-1.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $58.90 |
| 52-Week Low | $12.56 |
| Volume | 369.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.19M |
| Net Income | $-80.06M |
| Gross Margin | 0.25% |
6 analysts cover PLSE: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $62.33.